LOGIN  |  REGISTER
Astria Therapeutics
Viking Therapeutics

Addus HomeCare to Participate in Upcoming Investor Conferences in November

November 05, 2025 | Last Trade: US$114.43 0.69 -0.60

FRISCO, Texas / Nov 05, 2025 / Business Wire / Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced its participation at the following investor conferences in November:

  • 2025 UBS Global Healthcare Conference in Palm Beach Gardens, Florida. Dirk Allison, Chairman and Chief Executive Officer, Heather Dixon, President and Chief Operating Officer and Brian Poff, Executive Vice President and Chief Financial Officer, will present at 9:15 a.m. Central Time / 10:15 a.m. Eastern Time on Wednesday, November 12, 2025.
  • 2025 Stephens Annual Investment Conference in Nashville, Tennessee. Dirk Allison, Chairman and Chief Executive Officer, Heather Dixon, President and Chief Operating Officer and Brian Poff, Executive Vice President and Chief Financial Officer will present at 9:00 a.m. Central Time / 10:00 a.m. Eastern Time on Tuesday, November 18, 2025.

In connection with the conferences, there will be a live broadcast and replay of the Company’s presentation available under the Investor Relations section of the Company’s website, www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately one hour following the conclusion of the live broadcast.

About Addus HomeCare

Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to approximately 62,000 consumers through 265 locations across 23 states. For more information, please visit www.addus.com.

C4 Therapeutics

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page